BerandaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
$0,71
Setelah Jam Perdagangan Normal:(0,14%)-0,00100
$0,71
Tutup: 26 Jan, 20.00.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$0,72
Rentang hari
$0,71 - $0,75
Rentang tahun
$0,65 - $2,92
Kapitalisasi pasar
29,14Â jt USD
Volume Rata-Rata
71,51Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 5,00Â jt | -62,68% |
Penghasilan bersih | -14,57Â jt | -79,52% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,24 | -16,19% |
EBITDA | -10,12Â jt | -16,58% |
Tarif pajak efektif | 0,48% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 74,27Â jt | -30,00% |
Total aset | 109,20Â jt | -42,13% |
Total liabilitas | 24,64Â jt | -15,70% |
Total ekuitas | 84,56 jt | — |
Saham yang beredar | 40,83 jt | — |
Harga terhadap nilai buku | 0,35 | — |
Tingkat pengembalian aset | -21,41% | — |
Tingkat pengembalian modal | -24,28% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -14,57Â jt | -79,52% |
Kas dari operasi | -10,73Â jt | 41,06% |
Kas dari investasi | 451,00Â rb | 495,61% |
Kas dari pembiayaan | 0,00 | -100,00% |
Perubahan kas bersih | -12,11Â jt | -3,75% |
Arus kas bebas | -6,18Â jt | 66,42% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
105
